IL17A and metabolic dysfunction-associated steatotic liver disease: After adjusting for sex, age, BMI, TG, HDL-C, AST, ALT, HbA1c, and HOMA-IR, we found significant associations for IL-1β (OR = 1.16, 95% CI: 1.04–1.29, P = 0.007), IL-6 (OR = 1.27, 95% CI: 1.07–1.50, P = 0.006), and IL-17 (OR = 1.04, 95% CI: 1.02–1.06, P = 0.001) with NAFLD (Table 4).